YWHAQ and cancer: Recent advances in SiRNA based knockdown of 14-3-3 proteins as well as peptide inhibitors preventing dimerization of 14-3-3 such as R18 (difopein, a dimer of R18) [34] or small molecule compounds such as FOBISIN 101 [35] shows the promise of developing anti-14-3-3 therapy for cancer.